TTWM
AGN

TCV Trust & Wealth Management’s Allergan plc AGN Stock Holding History

TCV Trust & Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-713
Closed -$216K – 176
2015
Q2 		$216K Hold
713
– – 0.04% 165
2015
Q1 		$213K Buy
+713
New +$203K 0.03% 174
2014
Q4 		– Sell
-925
Closed -$223K – 176
2014
Q3 		$223K Buy
+925
New +$207K 0.04% 162

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TCV Trust & Wealth Management's AGN Position: Q3 2015 in Review

TCV Trust & Wealth Management sold out of Allergan plc (AGN) in Q3 2015, closing a stake of 713 shares — an estimated $216K sold.

TCV Trust & Wealth Management first reported a position in AGN in Q3 2014 and held it in 3 quarters. The position peaked at $223K in Q3 2014. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • TCV Trust & Wealth Management reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
  • TCV Trust & Wealth Management sold 713 Allergan plc shares in Q3 2015, an estimated $216K.
  • TCV Trust & Wealth Management first reported a position in Allergan plc in Q3 2014 and held it in 3 quarters.
  • TCV Trust & Wealth Management's Allergan plc position peaked at $223K in Q3 2014.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2015, filed 16 Oct 2015.